You are here: Industry Insights > API

News List

TIFAC releases report on status, issues, technology readiness and challenges in API production expresspharma
July 16, 2020
It was released along with a white paper on ‘Focused Interventions for ‘Make in India’: Post COVID 19’ which brought out the strengths, market trends, and opportunities in five sectors, including healthcare.
Biophore ramps up Made-In-India Favipiravir production for Covid-19 expresspharma
July 15, 2020
Biophore has received the DCGI license to manufacture the API in India and has been cleared for export as well.
CordenPharma Increases U.S. Peptide Manufacturing Capacity contractpharma
July 09, 2020
Expansion aims to accommodate a large spike in demand for peptide API’s.
CNS Pharmaceuticals Completes API Shipments to Manufacturers contractpharma
July 09, 2020
Supplies active ingredients for the production of Berubicin.
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy expresspharma
June 28, 2020
Companies investing in backward integration, new age technology, etc. would get the preference in the PLI scheme.
Bulk drug manufacturers seek support from govt, regulatory authorities expresspharma
June 28, 2020
Indian bulk drug manufacturers have requested the government and regulating authorities to bring some changes in the existing policies along with regulatory reforms to uplift the country’s API industry and work towards Aatmanirbhar Bharat.
Strategic short term measures needed on the API front: Pharma experts expresspharma
June 19, 2020
Experts feel that a multi-pronged strategy comprising both, short term and long term measures, are crucial to deal with the fall out of the COVID-19 pandemic as well as mounting friction between India and China.
Pharma MSMEs ask government to extend incentives of PLI scheme expresspharma
June 15, 2020
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits.
Government lifts export restrictions on HCQ APIs, formulations expresspharma
June 11, 2020
The government has lifted export restrictions on active pharmaceutical ingredients (API) and formulations of hydroxychloroquine (HCQ).
DGFT lifts export restrictions on paracetamol APIs expresspharma
May 29, 2020
It has removed the export restriction on ITC HS code 29222933 of paracetamol API, making it free for export with immediate effect.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 21 22 Next page